23andMe’s Post

Intriguing insights and tangible takeaways were the order of the day at this week's #BuchananLifeSciencesSummit in Philadelphia! Special thanks to: - Kimberly Banks MacKay, SVP, General Counsel and Corporate Secretary, #WestPharmaceuticalServices, and - Jennifer Sanfilippo, General Counsel & Chief Compliance Officer of #MelintaTherapeutics for engaging with me in a conversation about "Prioritizing the Priorities" as a Life Sciences Company's General Counsel. As Kimberly shared, prioritization is important but ultimately you have to do it all, and the question is "how will you shuffle the deck?" She noted that she hires lawyers for in-house roles who know that "if you came here to practice law, you came to the wrong place"- "we are running a business." Jennifer shared that buy-in from management is essential every step of the way. There are so many new legal and market developments - any one of which can be a company-altering event. It is essential to not get caught up in the minutiae. The Legal Department needs to be seen as a "facilitator for meeting business objectives." In addition, both speakers emphasized the need to use limited resources to their "highest and best use." The in-house legal department educates, and enables, business colleagues to make decisions that are informed and logical and based in sound legal and compliance principles. In my past, I have worked as a commercial litigator, and later as a pharmaceutical products liability litigator. I now counsel life sciences companies in a wide array of areas, and have, from time-to-time, had the privilege to work on-site supporting legal, compliance and regulatory departments at pharmaceutical and biotech industry companies. Our clients need expertise from many areas, but ultimately require one answer (that may reflect the evaluation and synthesis of diverse, yet interconnected, areas of legal expertise.) I also want to extend a special thank you to fellow Justice Marie L. Garibaldi law clerk Marjorie A. Adams of #FerringPharmaceuticals for sharing invaluable in-house insights on the final panel of the day: "Trade Secrets & Life Sciences: Protecting Value from Walking Out the Door" to close-out the day.

Navigating the Legal Maze: Overcoming Common Legal Challenges in the Cannabis Industry The cannabis industry is rapidly expanding, but it also presents a complex and ever-changing legal landscape. Businesses and individuals operating in this industry face a range of legal challenges, including: -Licensing and permitting -Regulatory compliance -Intellectual property protection -Taxation -Criminal law Learn more about how Mitchell Law's team of experienced cannabis attorneys can help you navigate these legal challenges and achieve your business goals in the cannabis industry. #MitchLawFirm #CannabisLaw #LegalChallenges #Compliance #CannabisIndustry

Gordon Rees Scully Mansukhani Partners J. Dominic Campodonico, Laura De Santos, Nancy Erfle, Ken Ferguson, and Michael Klatt have been recommended by Who's Who Legal ("WWL") in its 2024 Life Sciences Legal Marketplace Analysis under the Product Liability category. WWL: Life Sciences offers an in-depth examination of top-tier legal professionals worldwide who manage complex patent litigation and product liability cases, alongside regulatory and transactional affairs for prominent clients within the industry. Learn more on the Lexology website here: https://lnkd.in/g_VZkpvf. #productliability #productliabilitylaw #legalmarketplace #legal #law #lawyer #attorney #litigation #grsm #gordonrees #your50statelawfirm

In 2023, Delaware courts made significant decisions affecting different areas of intellectual property and corporate law, such as drug patent infringement, SPAC transactions, IPRs, and litigation funding disclosures. Get a great summary by some of the many experts here at Buchanan by viewing the video here. #Litigation #IP #IntellectualProperty #CorporateLaw #PatentLaw

Join moderator Shahiedah Shabazz in a thought-provoking discussion with Casey Grabenstein, Jeffery Lula, and Michael German as they explore unique aspects of cannabis litigation finance.🌿💼 Gain valuable resources for cannabis attorneys and their clients, exploring litigation finance as an innovative tool. Don't miss out on this insightful webinar! https://lnkd.in/eVuYQS23 #CannabisLaw #LitigationFinance #LegalInsights

In the News: Cannabis Company Acquisition Speculation 🌟 Discover the latest in the world of Corporate Law! Check out this insightful piece. 💡🌍 Explore our analysis of top cannabis companies as potential acquisition targets based on their market value and liquidation assets. 🔗 [Learn more: https://lnkd.in/eZWepN-J] #Legal #Corporate #Business #Law

Lessons were learned in late 2022 and H1 2023 where the proportion of IP litigation suits filed by non-practicing entities reached a seven-year high. How can businesses navigate these changing exposures? https://lnkd.in/e3bDmpSD #intellectualproperty #ip #iplitigation

Lessons were learned in late 2022 and H1 2023 where the proportion of IP litigation suits filed by non-practicing entities reached a seven-year high. How can businesses navigate these changing exposures? https://lnkd.in/e3bDmpSD #intellectualproperty #ip #iplitigation

In 2023, Delaware courts made notable decisions involving different areas of IP and corporate law, including drug patent infringement, SPAC transactions, IPRs, and litigation funding disclosures. #Litigation #IP #IntellectualProperty #CorporateLaw #PatentLaw

Lessons were learned in late 2022 and H1 2023 where the proportion of IP litigation suits filed by non-practicing entities reached a seven-year high. How can businesses navigate these changing exposures? https://lnkd.in/e3bDmpSD #intellectualproperty #ip #iplitigation